Marco Taglietti

Marco Taglietti possesses extensive leadership experience in the biopharmaceutical sector, currently serving as an Independent Board member at AUROBAC THERAPEUTICS and a Member of the Board of Directors at Aquestive Therapeutics and Orchestra of St. Luke. Previously, significant roles include Director on the National Board of American Foundation for Suicide Prevention and Director of BioNJ Board of Trustees. Marco held the position of President & Chief Executive Officer at SCYNEXIS and has been involved with multiple boards, including Delcath Systems, Inc., and NephroGenex. An accomplished professional with a medical background, Marco obtained degrees in medicine from Università di Pavia and holds board certifications in Dermatology and Infectious Diseases.